HIV Flashcards
HIV
Retrovirus (RNA-dependent DNA polymerase makes DNA as a replicative intermediary)
HIV characteristics
Virus binds to a specific receptor
Inserts viral genome into cell cytoplasm
Multiple steps in replicative process
Fusion of cells and loss of CD4 cells (helper T cells) results in immunodeficiency
Release of viral particles in productively infected cells
Integration of viral genome into resting cell genome
Infection progression
Initial infection- retroviral syndrome with fevers and adenopathy (similar to mononucleosis-like illness)
Quiescent period where infected individual may be relatively asymptomatic
Decline in CD4 helper T cells resulting in susceptibility to opportunistic infections
Characterization of status of HIV infection
Amt of virus present in serum (HIV RNA by PCR) and resistance pattern (20% of new infection occurs with resistant strains of HIV) Degree to which immunosuppression has occurred CD4 cell count Coinfection status -HPV -Hep C -Hep B -TB -VDs
Presentation of HIV
Retroviral syndrome
Asymptomatic
-Screening: pretty much everyone of sexually active age should be tested by EIA
Illness caused by opportunistic infection
Kaposi sarcoma
B cell lymphoma
Testing for HIV
HIV antibody testing
-2 enzyme-linked immunosorbent assay (ELIZA) tests FOLLOWED by Western blot analysis confirm HIV infection with a sensitivity >95%
HIV viral detection by PCR
CD4 marker measurement as a predictor of opportunistic infection risk
HIV tx approaches
Stop replication of HIV
Prevention of acquisition of HIV
HIV infection goals
Reduce HIV detection in serum to undetectable levels
Reduce risk of opportunistic infections when CD4 cell counts are low
Reduce transmission of HIV
How HIV is spread
Sex-all kinds Needles Maternal/fetal Not spread: Kissing Sharing meals Sharing school facilities Mosquitoes Toilet seats Govt conspiracies
Phase I of HIV infection
Acute infection: lasting from infection until seroconversion
Usually lasts 3-8 wks
Virus replicates to high titer (usually of R5 type)
Concluded when Cytotoxic-T Lymphocytes develop, seroconversion occurs, and virus is diminished in the blood
Phase II of HIV infection
Asymptomatic phase
Lasts for mos to .>15 mos
Continual virus replication
Active immune response and antigenic escape
Concluded by development of opportunistic infections
Phase III of HIV infection
Host immune response collapses
Clinical progression to AIDS
Syncytium inducing (X4 viruses) are common
Acute HIV-1 and seroconversion
> 50% of newly infected pts are asymptomatic
“Window period”- negative serology but high viremia
HIV test will be negative
Quantitative RNA by PCR will be very high
Prophylaxis
PCP when CD4 <200 (trim/sulfa, dapsone, or pentamidine)
MTB when ppd >5mm
MAC when CD4 <50-150 (azithro, clarithro, rifabutin)
MAC and PCP prophylaxis may be stopped in antiretroviral therapy responders
Costly/controversial: CMV, fungal infections
PAP smears with aggressive f/u
Fever: CD4 ~50-200
Bacterial pneumonia (>60% of hospital admissions for HIV-related fever) or pneumocystis (PCP) Sinusitis